{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:55:21Z","timestamp":1758819321588},"reference-count":53,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":1057,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Although it is well established that T cells derived from patients with atopic diseases produce low levels of interferon\u2010gamma (IFN\u2010\u03b3), the mechanisms responsible for this phenomenon are poorly understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To elucidate whether IFN\u2010\u03b3 production may be restored by co\u2010stimulatory molecules known to increase IFN\u2010\u03b3 production <jats:italic>in vitro<\/jats:italic>. Further, to investigate whether deficient IFN\u2010\u03b3 production is associated with disease activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Purified peripheral T cells obtained from patients with severe atopic dermatitis (AD), individuals with a history but no symptoms of AD and healthy control subjects were activated with anti\u2010CD3 MoAbs in the presence or absence of anti\u2010CD28 MoAbs, interleukin (IL\u2010) 12, IL\u20102, IL\u201015 or IL\u201018. IFN\u2010\u03b3 production was determined at the single cell level by flow cytometry, as well as by ELISA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Activated T cells from patients with severe AD produced less IFN\u2010\u03b3 than T cells from healthy control individuals. IL\u201012 or engagement of CD28 enhanced IFN\u2010\u03b3 production in both healthy and atopic T cells. However, absolute values of IFN\u2010\u03b3\u2003were still different. IL\u20102, IL\u201015 and IL\u201018 did not restore IFN\u2010\u03b3 production. T cells from individuals with a history of AD produced more IFN\u2010\u03b3 than those from subjects with severe AD, but less than T cells from healthy individuals. Atopic T cells expressed regular levels of CD3, CD28 and Stat4, the main signal transducer and activator of transcription for IL\u201012. IL\u20104, IL\u201010 and TGF\u2010\u03b2 production by T cells were not different between healthy and atopic individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IFN\u2010\u03b3 deficiency in atopic T cells is not due to a lack of responsiveness to CD28, IL\u201012, IL\u20102, IL\u201015 or IL\u201018. T cell\u2010derived cytokines able to antagonize IFN\u2010\u03b3 do not contribute to decreased IFN\u2010\u03b3 production. The extent of IFN\u2010\u03b3 deficiency seems to be dependent on disease activity.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2222.1999.00482.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T09:36:32Z","timestamp":1047375392000},"page":"207-216","source":"Crossref","is-referenced-by-count":10,"title":["IFN\u2010\u03b3 is only partially restored by co\u2010stimulation with IL\u201012, IL\u20102, IL\u201015, IL\u201018 or engagement of CD28"],"prefix":"10.1111","volume":"29","author":[{"family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Witzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Dieckhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Heidrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Aversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70049-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117408"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90185-6"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00371611"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12480966"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(92)90434-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb08098.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90213-8"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80010-7"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70286-5"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70296-2"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70030-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91641-1"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.1993.tb00068.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb00930.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.4.869"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.1.299"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.4049\/jimmunol.156.7.2413","article-title":"High\u2010dose IL\u20102 and IL\u201015 enhance the in vitro priming of naive CD4+ T cells for IFN\u2010gamma but have differential effects on priming for IL\u20104","volume":"156","author":"Seder RA","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/378088a0"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.5.1751"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(92)90082-P"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.2.571"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin JM","year":"1980","journal-title":"Acta Derm Venereol Suppl Stockh"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247298"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250843"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(93)90158-4"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260311"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.15.6419"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.233"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.4.1141"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5271.104"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1998.tb00310.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.11.6174"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.151.6.3345","article-title":"Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis","volume":"151","author":"Chan SC","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90011-X"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/382174a0"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5368.1435"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7307"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/382171a0"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12321078"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70246-4"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.11.5560"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00516.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60632-X"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80378-7"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12616114"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1997.278-ce1172.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.1996.tb00110.x"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1997.1180931.x"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1997.tb01169.x"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70171-4"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)80025-5"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236335"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1999.00482.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1999.00482.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.1999.00482.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T10:05:59Z","timestamp":1698573959000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.1999.00482.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1046\/j.1365-2222.1999.00482.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.1999.00482.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}